The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML - A randomized trial in patient-derived xenografts Meeting Abstract
| Authors: | Bruedigam, C.; Wackrow, B.; Song, A.; Porter, A. H.; Lee, S. C. W.; Moore, A. S.; Abdel-Wahab, O.; Lane, S. W. |
| Abstract Title: | The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML - A randomized trial in patient-derived xenografts |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394446802070 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.578.578 |
| Notes: | Meeting Abstract: 578 -- Source: Wos |
